StockData
TherapeuticsMD, Inc. logo

TherapeuticsMD, Inc. (TXMD) stock

TXMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 12/3029% below fair value
$1.81−0.06 (-3.21%)

Close on Nov 16, 2026Market cap $20.95MP/E –Yield –

Earnings

TherapeuticsMD's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 29, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q3 FY2026
$1.30M
+65.8% on a year earlier
Adjusted EPS, Q3 FY2026
$0.04
$0.00 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of TherapeuticsMD's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Mar 29, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Nov 13, 2026after the close$1.30M+65.8%$0.04–Release
Q2 FY2026ended Jun 30, 2026Aug 11, 2026during market hours$869.00K-13.1%––Release
Q1 FY2026ended Mar 31, 2026May 12, 2026during market hours$724.00K+84.2%––Release
Q4 FY2025ended Dec 31, 2025Mar 30, 2026during market hours––––Release
Q3 FY2025ended Sep 30, 2025Nov 13, 2025during market hours$784.00K+43.3%$0.00–Release
Q2 FY2025ended Jun 30, 2025Aug 12, 2025during market hours$1.00M+327.4%$0.05–Release
Q1 FY2025ended Mar 31, 2025May 13, 2025during market hours$393.00K+31.0%-$0.06–Release
Q4 FY2024ended Dec 31, 2024Mar 27, 2025during market hours––––Release
Q3 FY2024ended Sep 30, 2024Nov 12, 2024during market hours$547.00K–-$0.05–Release
Q2 FY2024ended Jun 30, 2024Aug 12, 2024during market hours$234.00K-41.5%-$0.09–Release
Q1 FY2024ended Mar 31, 2024May 10, 2024during market hours$300.00K-25.0%-$0.07–Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

TherapeuticsMD has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When TherapeuticsMD puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases TherapeuticsMD filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Results
  5. Results
  6. Results
  7. Results
  8. Results
  9. Results
  10. Results
  11. Results
  12. Results
  13. Results
  14. Results
  15. Results

See a number that looks wrong?